- List of Appointed Distributors Under Special Conditions of Type A License
- Guideline for the Management of Medicine Donations
- Ministry of Health Medicines Formulary (MOHMF)
- Guidelines for Pharmacists on the Application for Permission to Sell Compounded Preparations at Community Pharmacy Premises and Notification of Compounded Preparations
- Medicine Prices Monitoring Survey In Malaysia 2022
Related FAQ
Contact Us
Lot 36,
Jalan Universiti (Jalan Prof Diraja Ungku Aziz),
46200 Petaling Jaya, Selangor.
[ Location map ]
Phone: 603-7841 3200
Fax: 603-7968 2222
You are here
Position Statements on the Use of Biosimilars in the Ministry of Health, Malaysia Healthcare Facilities

The increasing use of biological medicines including biosimilars in the Ministry of Health (MOH), Malaysia facilities warrants a suitable guidance document to ensure safe and appropriate prescribing and dispensing practices.
This position statement acts as a guidance to the use and handling of biosimilars in healthcare facilities under the purview of the Ministry of Health (MOH), Malaysia. It should also be read along with the Guidance Document and Guidelines for Registration of Biosimilars in Malaysia, 2008. This position statement covers the principles and practical issues around biosimilar use as well as the requirement for ongoing pharmacovigilance and outcome monitoring.
- 1760 reads